BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPR
1551
DELISTED
Spirit AeroSystems
SPR
| $153M | 0.01% |
6,400,190
-476,957
| -7% | -$10.8M |
|
1552
AtriCure
ATRC
$2.12B
| $153M | 0.01% |
3,403,081
+299,024
| +10% | +$13M |
|
1553
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $152M | 0.01% |
2,522,340
+843,750
| +50% | +$49.4M |
|
1554
10x Genomics
TXG
$7.32B
| $152M | 0.01% |
1,703,738
+1,238,609
| +266% | +$96.5M |
|
1555
Enanta Pharmaceuticals
ENTA
$398M
| $152M | 0.01% |
3,030,291
+198,393
| +7% | +$10.3M |
|
1556
Mativ Holdings
MATV
$695M
| $152M | 0.01% |
4,553,517
+65,860
| +1% | +$1.98M |
|
|
ISBC
1557
DELISTED
Investors Bancorp, Inc.
ISBC
| $152M | 0.01% |
17,872,957
-215,591
| -1% | -$1.81M |
|
1558
Eagle Bancorp
EGBN
$842M
| $152M | 0.01% |
4,632,243
-204,711
| -4% | -$6.53M |
|
1559
Belden
BDC
$5.24B
| $152M | 0.01% |
4,655,126
+168,704
| +4% | +$5.61M |
|
1560
Denali Therapeutics
DNLI
$3.95B
| $151M | 0.01% |
6,257,582
+991,226
| +19% | +$23.3M |
|
1561
ATI
ATI
$31.2B
| $151M | 0.01% |
14,811,973
-116,639
| -0.8% | -$1.01M |
|
1562
iShares MSCI South Korea ETF
EWY
$25.4B
| $151M | 0.01% |
2,638,930
+910,657
| +53% | +$48.1M |
|
|
DRNA
1563
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $151M | 0.01% |
5,934,280
+875,733
| +17% | +$18.9M |
|
1564
United Natural Foods
UNFI
$2.81B
| $151M | 0.01% |
8,271,910
+187,953
| +2% | +$2.82M |
|
1565
Avis
CAR
$4.97B
| $150M | 0.01% |
6,569,336
-286,914
| -4% | -$5.26M |
|
1566
Encore Capital Group
ECPG
$2.06B
| $150M | 0.01% |
4,398,095
+22,320
| +0.5% | +$665K |
|
1567
Workiva
WK
$3.61B
| $150M | 0.01% |
2,809,402
+146,210
| +5% | +$5.99M |
|
1568
Dycom Industries
DY
$12.2B
| $150M | 0.01% |
3,667,675
-145,920
| -4% | -$5.04M |
|
|
CYBR
1569
DELISTED
CyberArk
CYBR
| $150M | 0.01% |
1,509,252
+199,422
| +15% | +$19.4M |
|
1570
Ironwood Pharmaceuticals
IRWD
$673M
| $149M | 0.01% |
14,468,180
+1,127,914
| +8% | +$11.5M |
|
|
ALTR
1571
DELISTED
Altair Engineering Inc
ALTR
| $149M | 0.01% |
3,746,122
+468,590
| +14% | +$15.9M |
|
|
CSR
1572
Centerspace
CSR
$935M
| $149M | 0.01% |
2,110,554
+95,796
| +5% | +$6.12M |
|
|
DHR.PRA
1573
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $149M | 0.01% |
119,227
-5,309
| -4% | -$6.26M |
|
1574
Strategy Inc
MSTR
$37.3B
| $149M | 0.01% |
12,566,220
-1,063,390
| -8% | -$12.9M |
|
1575
Amphastar Pharmaceuticals
AMPH
$890M
| $149M | 0.01% |
6,611,928
+404,763
| +7% | +$7.41M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.